First Allied Advisory Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

First Allied Advisory Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$2K	–	1261
2017 Q4	$2K	Buy	+100	New	+$2.06K	﹤0.01%	1514

Other funds holding FTXH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

First Allied Advisory Services's FTXH Position: Q1 2018 in Review

First Allied Advisory Services sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2018, closing a stake of 100 shares — an estimated $2K sold.

First Allied Advisory Services first reported a position in FTXH in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 5 funds tracked by Wall St. Rank hold FTXH as of Q1 2018.

First Allied Advisory Services reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
First Allied Advisory Services sold 100 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2018, an estimated $2K.
First Allied Advisory Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2017 and held it in 1 quarter.
First Allied Advisory Services's First Trust Nasdaq Pharmaceuticals ETF position peaked at $2K in Q4 2017.
5 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2018.

Based on First Allied Advisory Services's 13F filing for Q1 2018, filed 11 May 2018.